Novonesis (Novozymes) A/S (NSIS-B) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Novonesis (Novozymes) A/S (NSIS-B) has a cash flow conversion efficiency ratio of 0.015x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr167.06 Million ≈ $26.14 Million USD) by net assets (Dkr10.92 Billion ≈ $1.71 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Novonesis (Novozymes) A/S net asset quality index to measure how much of total assets are equity-financed.
Novonesis (Novozymes) A/S - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Novonesis (Novozymes) A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Novonesis (Novozymes) A/S's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Novonesis (Novozymes) A/S Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Novonesis (Novozymes) A/S ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NRG Energy Inc.
NYSE:NRG
|
-0.035x |
|
ACS A.DE C.ADR 1/5/EO-50
F:OCI
|
0.282x |
|
Otis Worldwide Corp
NYSE:OTIS
|
-0.071x |
|
Sampo A SDB
ST:SAMPO-SDB
|
0.002x |
|
Standard Bank Group Ltd
JSE:SBK
|
0.252x |
|
Amrize Ltd
NYSE:AMRZ
|
0.066x |
|
Trip.com Group Limited
F:CLV
|
0.014x |
|
ZIJIN MIN.H UNSP.ADR/20
F:FJZB
|
N/A |
Annual Cash Flow Conversion Efficiency for Novonesis (Novozymes) A/S (2002–2025)
The table below shows the annual cash flow conversion efficiency of Novonesis (Novozymes) A/S from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see Novonesis (Novozymes) A/S (NSIS-B) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Dkr10.86 Billion ≈ $1.70 Billion |
Dkr1.22 Billion ≈ $191.11 Million |
0.113x | +23.31% |
| 2024-12-31 | Dkr11.18 Billion ≈ $1.75 Billion |
Dkr1.02 Billion ≈ $159.57 Million |
0.091x | -68.46% |
| 2023-12-31 | Dkr14.35 Billion ≈ $2.25 Billion |
Dkr4.15 Billion ≈ $649.61 Million |
0.289x | +2.76% |
| 2022-12-31 | Dkr14.23 Billion ≈ $2.23 Billion |
Dkr4.01 Billion ≈ $626.77 Million |
0.282x | -15.39% |
| 2021-12-31 | Dkr12.21 Billion ≈ $1.91 Billion |
Dkr4.06 Billion ≈ $635.53 Million |
0.333x | -14.08% |
| 2020-12-31 | Dkr11.24 Billion ≈ $1.76 Billion |
Dkr4.36 Billion ≈ $681.37 Million |
0.387x | +39.12% |
| 2019-12-31 | Dkr11.48 Billion ≈ $1.80 Billion |
Dkr3.20 Billion ≈ $500.04 Million |
0.278x | -13.45% |
| 2018-12-31 | Dkr11.44 Billion ≈ $1.79 Billion |
Dkr3.68 Billion ≈ $575.61 Million |
0.322x | -10.80% |
| 2017-12-31 | Dkr11.27 Billion ≈ $1.76 Billion |
Dkr4.06 Billion ≈ $635.69 Million |
0.361x | +10.30% |
| 2016-12-31 | Dkr11.74 Billion ≈ $1.84 Billion |
Dkr3.84 Billion ≈ $600.80 Million |
0.327x | +13.52% |
| 2015-12-31 | Dkr11.59 Billion ≈ $1.81 Billion |
Dkr3.34 Billion ≈ $522.41 Million |
0.288x | -28.20% |
| 2014-12-31 | Dkr11.28 Billion ≈ $1.76 Billion |
Dkr4.53 Billion ≈ $707.97 Million |
0.401x | +70.80% |
| 2013-12-31 | Dkr11.07 Billion ≈ $1.73 Billion |
Dkr2.60 Billion ≈ $406.63 Million |
0.235x | -18.52% |
| 2012-12-31 | Dkr9.57 Billion ≈ $1.50 Billion |
Dkr2.76 Billion ≈ $431.51 Million |
0.288x | -6.11% |
| 2011-12-31 | Dkr8.82 Billion ≈ $1.38 Billion |
Dkr2.71 Billion ≈ $423.84 Million |
0.307x | +3.51% |
| 2010-12-31 | Dkr7.84 Billion ≈ $1.23 Billion |
Dkr2.32 Billion ≈ $363.61 Million |
0.297x | -4.50% |
| 2009-12-31 | Dkr5.85 Billion ≈ $915.43 Million |
Dkr1.82 Billion ≈ $284.28 Million |
0.311x | -18.09% |
| 2008-12-31 | Dkr4.48 Billion ≈ $700.30 Million |
Dkr1.70 Billion ≈ $265.51 Million |
0.379x | -18.89% |
| 2007-12-31 | Dkr3.67 Billion ≈ $573.73 Million |
Dkr1.71 Billion ≈ $268.17 Million |
0.467x | +3.39% |
| 2006-12-31 | Dkr3.39 Billion ≈ $530.86 Million |
Dkr1.53 Billion ≈ $240.01 Million |
0.452x | +29.36% |
| 2005-12-31 | Dkr3.79 Billion ≈ $593.60 Million |
Dkr1.33 Billion ≈ $207.46 Million |
0.349x | +5.69% |
| 2004-12-31 | Dkr3.89 Billion ≈ $608.93 Million |
Dkr1.29 Billion ≈ $201.36 Million |
0.331x | +0.48% |
| 2003-12-31 | Dkr4.17 Billion ≈ $653.21 Million |
Dkr1.37 Billion ≈ $214.97 Million |
0.329x | +18.38% |
| 2002-12-31 | Dkr4.25 Billion ≈ $664.63 Million |
Dkr1.18 Billion ≈ $184.78 Million |
0.278x | -- |
About Novonesis (Novozymes) A/S
Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The c… Read more